Header Logo

Sebastian Pollandt

Concepts (124)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Seizures
2
2020
88
1.250
Why?
Epilepsy
2
2020
105
1.230
Why?
Amygdala
9
2015
50
1.090
Why?
Long-Term Potentiation
7
2015
12
0.910
Why?
Cocaine
6
2011
46
0.640
Why?
Body Temperature Regulation
1
2018
11
0.610
Why?
Hematoma, Subdural, Acute
1
2017
8
0.570
Why?
Dopamine Uptake Inhibitors
4
2010
16
0.460
Why?
Receptors, Corticotropin-Releasing Hormone
3
2006
6
0.420
Why?
Synaptic Transmission
5
2011
46
0.360
Why?
Receptors, Metabotropic Glutamate
3
2015
17
0.330
Why?
Receptors, N-Methyl-D-Aspartate
3
2011
34
0.310
Why?
Corticotropin-Releasing Hormone
4
2010
7
0.300
Why?
Synapses
2
2011
49
0.290
Why?
Brain
1
2017
1726
0.290
Why?
Cyclic AMP-Dependent Protein Kinases
1
2006
30
0.280
Why?
Substance Withdrawal Syndrome
4
2011
36
0.280
Why?
Electroencephalography
2
2017
142
0.250
Why?
Animals
11
2018
4634
0.240
Why?
Rats
9
2015
873
0.240
Why?
Phospholipase D
2
2015
5
0.230
Why?
8-Hydroxy-2-(di-n-propylamino)tetralin
1
2003
3
0.220
Why?
Serotonin Receptor Agonists
1
2003
9
0.220
Why?
Receptors, Serotonin
1
2003
20
0.220
Why?
Rats, Sprague-Dawley
8
2015
463
0.210
Why?
Status Epilepticus
1
2020
50
0.180
Why?
Dopamine
2
2011
161
0.160
Why?
Child
1
2020
1376
0.140
Why?
Behavior, Animal
3
2011
107
0.130
Why?
Reflex, Startle
1
2015
4
0.130
Why?
Anticonvulsants
1
2017
111
0.130
Why?
Male
11
2017
15844
0.130
Why?
Fear
1
2015
47
0.130
Why?
Prefrontal Cortex
2
2008
152
0.130
Why?
Comorbidity
1
2017
504
0.120
Why?
Hematoma, Subdural
1
2015
9
0.120
Why?
Cortical Spreading Depression
1
2014
1
0.120
Why?
Humans
6
2020
29801
0.120
Why?
Lung Diseases
1
2015
46
0.120
Why?
gamma-Aminobutyric Acid
2
2011
49
0.120
Why?
Incidence
1
2017
759
0.120
Why?
Brain Injuries
1
2014
48
0.120
Why?
Respiration, Artificial
1
2015
109
0.110
Why?
In Vitro Techniques
3
2010
214
0.110
Why?
Adult
3
2020
8730
0.100
Why?
Neuronal Plasticity
1
2011
43
0.100
Why?
Treatment Outcome
2
2017
3557
0.090
Why?
Retrospective Studies
2
2017
3325
0.090
Why?
Drug Interactions
2
2010
68
0.090
Why?
Receptors, Dopamine
1
2010
30
0.090
Why?
Cocaine-Related Disorders
2
2006
18
0.090
Why?
Dose-Response Relationship, Drug
2
2010
455
0.080
Why?
Drug Administration Schedule
2
2006
232
0.080
Why?
Female
4
2017
16402
0.080
Why?
Aged
3
2017
9618
0.080
Why?
Postoperative Complications
1
2015
957
0.080
Why?
Excitatory Postsynaptic Potentials
3
2015
12
0.080
Why?
Excitatory Amino Acid Agonists
1
2006
3
0.070
Why?
Excitatory Amino Acid Antagonists
1
2006
23
0.070
Why?
Glutamic Acid
1
2006
32
0.070
Why?
Electric Stimulation
3
2015
83
0.070
Why?
Enzyme Activation
1
2006
112
0.070
Why?
Enzyme Inhibitors
1
2006
147
0.070
Why?
Tissue Culture Techniques
1
2005
11
0.070
Why?
Patch-Clamp Techniques
3
2011
115
0.060
Why?
Pyramidal Cells
1
2005
44
0.060
Why?
Glycine
2
2015
12
0.060
Why?
Cyclopropanes
2
2015
26
0.060
Why?
Receptors, Serotonin, 5-HT1
1
2003
1
0.060
Why?
Serotonin Antagonists
1
2003
19
0.060
Why?
Rats, Wistar
1
2003
45
0.050
Why?
Neural Pathways
2
2015
82
0.050
Why?
Evoked Potentials
2
2014
19
0.050
Why?
Cues
2
2011
61
0.040
Why?
Dopamine Agents
2
2010
40
0.040
Why?
Young Adult
2
2015
1966
0.040
Why?
Memory, Long-Term
1
2015
1
0.030
Why?
Conditioning, Classical
1
2015
7
0.030
Why?
Fructose-Bisphosphate Aldolase
1
2015
4
0.030
Why?
Thalamus
1
2015
28
0.030
Why?
Disease Models, Animal
2
2010
744
0.030
Why?
Survivors
1
2015
57
0.030
Why?
Ventilator Weaning
1
2015
35
0.030
Why?
Functional Laterality
1
2014
94
0.030
Why?
Time Factors
2
2010
1640
0.030
Why?
Intubation, Intratracheal
1
2015
78
0.030
Why?
Patient Discharge
1
2015
151
0.030
Why?
Neurosurgical Procedures
1
2015
152
0.030
Why?
Length of Stay
1
2015
320
0.030
Why?
Radiography
1
2015
678
0.030
Why?
Raclopride
1
2011
1
0.020
Why?
Receptors, Dopamine D5
1
2011
1
0.020
Why?
Receptors, Dopamine D1
1
2011
8
0.020
Why?
Critical Care
1
2014
242
0.020
Why?
Benzazepines
1
2011
9
0.020
Why?
Gene Expression Regulation, Enzymologic
1
2011
29
0.020
Why?
Receptor, Cannabinoid, CB2
1
2011
1
0.020
Why?
Picrotoxin
1
2011
2
0.020
Why?
Receptor, Cannabinoid, CB1
1
2011
2
0.020
Why?
GABA Antagonists
1
2011
3
0.020
Why?
Isoenzymes
1
2011
54
0.020
Why?
Receptor, Metabotropic Glutamate 5
1
2011
15
0.020
Why?
Middle Aged
2
2015
9952
0.020
Why?
GABA Agents
1
2010
1
0.020
Why?
Excitatory Amino Acid Agents
1
2010
1
0.020
Why?
Models, Neurological
1
2010
32
0.020
Why?
Memory
1
2011
323
0.020
Why?
Adolescent
1
2015
2331
0.020
Why?
Guanosine Diphosphate
1
2008
3
0.020
Why?
Thionucleotides
1
2008
6
0.020
Why?
Inhibitory Postsynaptic Potentials
1
2008
2
0.020
Why?
Animals, Newborn
1
2008
58
0.020
Why?
Drug Synergism
1
2008
66
0.020
Why?
Motor Activity
1
2010
372
0.020
Why?
Calcium Channels, L-Type
1
2006
57
0.020
Why?
Stress, Physiological
1
2006
20
0.020
Why?
Models, Biological
1
2008
347
0.020
Why?
Limbic System
1
2005
11
0.020
Why?
Central Nervous System
1
2006
55
0.020
Why?
Neocortex
1
2005
34
0.020
Why?
Nerve Net
1
2005
54
0.020
Why?
Aged, 80 and over
1
2015
4930
0.020
Why?
Chronic Disease
1
2006
508
0.010
Why?
Cells, Cultured
1
2005
682
0.010
Why?
Pollandt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (124)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_